WG
ASMB icon

Winton Group’s Assembly Biosciences ASMB Stock Holding History

Winton Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-665
Closed -$297K – 861
2018
Q3 		$297K Sell
665
-211
-24% -$98.8K 0.01% 819
2018
Q2 		$412K Sell
876
-378
-30% -$200K 0.01% 709
2018
Q1 		$740K Buy
+1,254
New +$778K 0.02% 615

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Winton Group's ASMB Position: Q4 2018 in Review

Winton Group sold out of Assembly Biosciences (ASMB) in Q4 2018, closing a stake of 665 shares — an estimated $297K sold.

Winton Group first reported a position in ASMB in Q1 2018 and held it in 3 quarters. The position peaked at $740K in Q1 2018. 106 funds tracked by Wall St. Rank hold ASMB as of Q4 2018.

  • Winton Group reported no remaining Assembly Biosciences position as of Q4 2018 after selling out during the quarter.
  • Winton Group sold 665 Assembly Biosciences shares in Q4 2018, an estimated $297K.
  • Winton Group first reported a position in Assembly Biosciences in Q1 2018 and held it in 3 quarters.
  • Winton Group's Assembly Biosciences position peaked at $740K in Q1 2018.
  • 106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2018.

Based on Winton Group's 13F filing for Q4 2018, filed 5 Feb 2019.